First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

Smit, Merel J.; Sander, Adam F.; Ariaans, Maud B. P. A.; Fougeroux, Cyrielle; Heinzel, Constanze; Fendel, Rolf; Esen, Meral; Kremsner, Peter G.; ter Heine, Rob; Wertheim, Heiman F.; Idorn, Manja; Underwood, Alexander P.; Binderup, Alekxander; Ramirez, Santseharay; Bukh, Jens; Soegaard, Max; Erdogan, Sayit M.; Gustavsson, Tobias; Clemmensen, Stine; Theander, Thor G.; Microbe, Lancet; Salanti, Ali; Hamborg, Mette; de Jongh, Willem A.; McCall, Matthew B. B.; Nielsen, Morten A.; Mordmuller, Benjamin G.

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

Autor(en):

Smit, Merel J.; Sander, Adam F.; Ariaans, Maud B. P. A.; Fougeroux, Cyrielle; Heinzel, Constanze; Fendel, Rolf; Esen, Meral; Kremsner, Peter G.; ter Heine, Rob; Wertheim, Heiman F.; Idorn, Manja; Underwood, Alexander P.; Binderup, Alekxander; Ramirez, Santseharay; Bukh, Jens; Soegaard, Max; Erdogan, Sayit M.; Gustavsson, Tobias; Clemmensen, Stine; Theander, Thor G.; Microbe, Lancet; Salanti, Ali; Hamborg, Mette; de Jongh, Willem A.; McCall, Matthew B. B.; Nielsen, Morten A.; Mordmuller, Benjamin G.

Tübinger Autor(en):

Heinzel, Constanze
Fendel, Rolf
Esen, Meral
Kremsner, Peter
McCall, Matthew

Erschienen in:

Lancet Microbe (2023), Bd. 4, H. 3, S. E140-E148

Verlagsangabe:

Elsevier

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S2666-5247(22)00337-8

ISSN:

2666-5247